Chronic diarrhoea: Definition, classification and diagnosis;Diarrea crónica: definición, clasificación y diagnóstico

Gastroenterologia y Hepatologia

Volumn 39, Issue 8, 2016, Pages 535-559

  Fernández Bañares, Fernando ^a,i   Accarino, Anna ^b,i   Balboa, Agustín ^c   Domènech, Eugeni ^d,i   Esteve, Maria ^a,i   Garcia Planella, Esther ^e   Guardiola, Jordi ^f   Molero, Xavier ^b,i   Rodríguez Luna, Alba ^g   Ruiz Cerulla, Alexandra ^f   Santos, Javier ^b,i   Vaquero, Eva ^h,i  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c Unidad de Parkinson   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^f HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^g Medicina de Familia   (Spain)

^h HOSPITAL CLÍNIC   (Spain)

ⁱ INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Chronic diarrhoea; Consensus document; Evidence based recommendations; GRADE system

Indexed keywords

ALGORITHM; CHRONIC DIARRHEA; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CONSENSUS; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; EVIDENCE BASED MEDICINE; GASTROENTEROLOGY; HEALTH CARE PERSONNEL; HUMAN; MEDICAL CARE; MEDICAL SOCIETY; MEDICAL SPECIALIST; PATIENT CARE; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PROGRAM DEVELOPMENT; SHORT SURVEY; SYMPTOM; CHRONIC DISEASE; CLASSIFICATION; COLITIS; COMPLICATION; CONSENSUS DEVELOPMENT; DIARRHEA; DIET; DIGESTIVE SYSTEM EXAMINATION; DISEASE MANAGEMENT; EXOCRINE PANCREATIC INSUFFICIENCY; FOOD ALLERGY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; INTESTINE FLORA; MALABSORPTION; PRACTICE GUIDELINE; SUGAR INTAKE;

ANTIDIARRHEAL AGENT;

ALGORITHMS; ANTIDIARRHEALS; CHRONIC DISEASE; COLITIS; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; DIARRHEA; DIET; DIETARY SUGARS; DISEASE MANAGEMENT; EXOCRINE PANCREATIC INSUFFICIENCY; FOOD HYPERSENSITIVITY; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL MOTILITY; HUMANS; MALABSORPTION SYNDROMES;

EID: 84990234071     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2015.09.018     Document Type: Short Survey

References (125)

1. Headstrom, P.D., Surawicz, C.M., Chronic diarrhea. Clin Gastroenterol Hepatol. 3 (2005), 734–737.
2. Schiller, L.R., Pardi, D.S., Spiller, R., Semrad, C.E., Surawicz, C.M., Giannella, R.A., et al. Gastro 2013 APDW/WCOG Shanghai working party report: Chronic diarrhea: Definition, classification, diagnosis. J Gastroenterol Hepatol. 29 (2014), 6–25.
3. Sandhu, D.K., Surawicz, C., Update on chronic diarrhea: A run-through for the clinician. Curr Gastroenterol Rep. 14 (2012), 421–427.
4. Fine, K.D., Schiller, L.R., AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology. 116 (1999), 1464–1486.
5. Thomas, P.D., Forbes, A., Green, J., Howdle, P., Long, R., Playford, R., et al. Guidelines for the investigation of chronic diarrhoea, 2 nd edition. Gut, 52(Suppl 5), 2003 v1- 15.
6. Gentile, N.M., Khanna, S., Loftus, E.V. Jr., Smyrk, T.C., Tremaine, W.J., Harmsen, W.S., et al. The epidemiology of microscopic colitis in Olmsted County from 2002 to 2010: A population-based study. Clin Gastroenterol Hepatol. 12 (2014), 838–842.
7. Fernández-Bañares, F., Esteve, M., Salas, A., Alsina, M., Farré, C., González, C., et al. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am J Gastroenterol. 102 (2007), 2520–2528.
8. Habba, S.F., Diarrhea predominant Irritable Bowel Syndrome (IBS-D): Fact or fiction. Med Hypotheses. 76 (2011), 97–99.
9. Marzo-Castillejo, M., Alonso-Coello, P., Rotaeche del Campo, R., How are the quality of evidence and the strength of recommendations to be classified?. Aten Primaria. 37 (2006), 5–8.
10. Waugh, N., Cummins, E., Royle, P., Kandala, N.B., Shyangdan, D., Arasaradnam, R., et al. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: Systematic review and economic evaluation. Health Technol Assess., 17, 2013 xv-xix, 1-211.
11. Van Rheenen, P.F., van de Vijver, E., Fidler, V., Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: Diagnostic meta-analysis. BMJ., 341, 2010 3369.
12. Panes, J., Bouhnik, Y., Reinisch, W., Stoker, J., Taylor, S.A., Baumgart, D.C., et al. Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis. 7 (2013), 556–585.
13. Rodríguez-Pardo, D., Mirelis, B., Navarro, F., Infections caused by Clostridium difficile. Enferm Infecc Microbiol Clin. 31 (2013), 254–263.
14. Cone, M.M., Whitlow, C.B., Sexually transmitted and anorectal infectious diseases. Gastroenterol Clin North Am. 42 (2013), 877–892.
15. Koot, B.G., ten Kate, F.J., Juffrie, M., Rosalina, I., Taminiau, J.J., Benninga, M.A., Does Giardia lamblia cause villous atrophy in children? A retrospective cohort study of the histological abnormalities in giardiasis. J Pediatr Gastroenterol Nutr. 49 (2009), 304–308.
16. Ianiro, G., Bibbò, S., Montalto, M., Ricci, R., Gasbarrini, A., Cammarota, G., Systematic review: Sprue-like enteropathy associated with olmesartan. Aliment Pharmacol Ther. 40 (2014), 16–23.
17. Brown, I.S., Bettington, A., Bettington, M., Rosty, C., Tropical sprue: revisiting an underrecognized disease. Am J Surg Pathol. 38 (2014), 666–672.
18. Haghighi, P., Wolf, P.L., Tropical sprue and subclinical enteropathy: A vision for the nineties. Crit Rev Clin Lab Sci. 34 (1997), 313–341.
19. Pallav, K., Leffler, D.A., Tariq, S., Kabbani, T., Hansen, J., Peer, A., et al. Noncoeliac enteropathy: The differential diagnosis of villous atrophy in contemporary clinical practice. Aliment Pharmacol Ther. 35 (2012), 380–390.
20. Rubio-Tapia, A., Murray, J.A., Classification and management of refractory coeliac disease. Gut. 59 (2010), 547–557.
21. Lagier, J.C., Lepidi, H., Raoult, D., Fenollar, F., Systemic Tropheryma whipplei: Clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Medicine (Baltimore). 89 (2010), 337–345.
22. Marsh, M.N., Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (’celiac sprue’). Gastroenterology. 102 (1992), 330–354.
23. Oberhuber, G., Granditsch, G., Vogelsang, H., The histopathology of coeliac disease: Time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 11 (1999), 1185–1194.
24. Corazza, G.R., Villanacci, V., Coeliac disease. J Clin Pathol. 58 (2005), 573–574.
25. Ensari, A., Gluten-sensitive enteropathy (celiac disease): Controversies in diagnosis and classification. Arch Pathol Lab Med. 134 (2010), 826–836.
26. Rubio-Tapia, A., Hill, I.D., Kelly, C.P., Calderwood, A.H., Murray, J.A., Gastroenterology ACo. ACG clinical guidelines: Diagnosis and management of celiac disease. Am J Gastroenterol 108 (2013), 656–676 (): quiz 677.
27. Catassi, C., Fasano, A., Celiac disease diagnosis: Simple rules are better than complicated algorithms. Am J Med. 123 (2010), 691–693.
28. Langenberg, M.C., Wismans, P.J., van Genderen, P.J., Distinguishing tropical sprue from celiac disease in returning travellers with chronic diarrhoea: A diagnostic challenge?. Travel Med Infect Dis. 12 (2014), 401–405.
29. Liu, H., Brais, R., Lavergne-Slove, A., Jeng, Q., Payne, K., Ye, H., et al. Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac disease. Gut. 59 (2010), 452–460.
30. O'Malley, D.P., Goldstein, N.S., Banks, P.M., The recognition and classification of lymphoproliferative disorders of the gut. Hum Pathol. 45 (2014), 899–916.
31. Gabrielli, M., d'Angelo, G., di Rienzo, T., Scarpellini, E., Ojetti, V., Diagnosis of small intestinal bacterial overgrowth in the clinical practice. Eur Rev Med Pharmacol Sci. 17:Suppl 2 (2013), 30–35.
32. Miazga, A., Osiński, M., Cichy, W., Żaba, R., Current views on the etiopathogenesis, clinical manifestation, diagnostics, treatment and correlation with other nosological entities of SIBO. Adv Med Sci. 60 (2015), 118–124.
33. Saad, R.J., Chey, W.D., Breath testing for small intestinal bacterial overgrowth: Maximizing test accuracy. Clin Gastroenterol Hepatol 12 (2014), 1964–1972 (): quiz e119-20.
34. Gasbarrini, A., Corazza, G.R., Gasbarrini, G., Montalto, M., Di Stefano, M., Basilisco, G., et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: The Rome Consensus Conference. Aliment Pharmacol Ther. 29:Suppl 1 (2009), 1–49.
35. DiMagno, E.P., Medical treatment of pancreatic insufficiency. Mayo Clin Proc. 54 (1979), 435–442.
36. Bollbach, R., Becker, M., Rotthauwe, H.W., Serum immunoreactive trypsin and pancreatic lipase in cystic fibrosis. Eur J Pediatr. 144 (1985), 167–170.
37. Cleghorn, G., Benjamin, L., Corey, M., Forstner, G., Dati, F., Durie, P., Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis. Pediatrics. 77 (1986), 301–306.
38. Ammann, R.W., Bühler, H., Pei, P., Comparative diagnostic accuracy of four tubeless pancreatic function tests in chronic pancreatitis. Scand J Gastroenterol. 17 (1982), 997–1002.
39. Lankisch, P.G., Koop, H., Otto, J., Estimation of serum pancreatic isoamylase: Its role in the diagnosis of exocrine pancreatic insufficiency. Am J Gastroenterol. 81 (1986), 365–368.
40. Pezzilli, R., Talamini, G., Gullo, L., Behaviour of serum pancreatic enzymes in chronic pancreatitis. Dig Liver Dis. 32 (2000), 233–237.
41. Löser, C., Möllgaard, A., Fölsch, U.R., Faecal elastase 1: A novel, highly sensitive, and specific tubeless pancreatic function test. Gut. 39 (1996), 580–586.
42. Benini, L., Amodio, A., Campagnola, P., Agugiaro, F., Cristofori, C., Micciolo, R., et al. Fecal elastase-1 is useful in the detection of steatorrhea in patients with pancreatic diseases but not after pancreatic resection. Pancreatology. 13 (2013), 38–42.
43. Halloran, C.M., Cox, T.F., Chauhan, S., Raraty, M.G., Sutton, R., Neoptolemos, J.P., et al. Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: A prospective study. Pancreatology. 11 (2011), 535–545.
44. Goldberg, D.M., Proteases in the evaluation of pancreatic function and pancreatic disease. Clin Chim Acta. 291 (2000), 201–221.
45. De Pedro, C., Codoceo, R., Vazquez, P., Hernanz, A., Fecal chymotrypsin levels in children with pancreatic insufficiency. Clin Biochem. 19 (1986), 338–340.
46. Vantrappen, G.R., Rutgeerts, P.J., Ghoos, Y.F., Hiele, M.I., Mixed triglyceride breath test: A noninvasive test of pancreatic lipase activity in the duodenum. Gastroenterology. 96 (1989), 1126–1134.
47. Heikius, B., Niemelä, S., Lehtola, J., Karttunen, T., Lähde, S., Pancreatic duct abnormalities and pancreatic function in patients with chronic inflammatory bowel disease. Scand J Gastroenterol. 31 (1996), 517–523.
48. Muniz, C.K., dos Santos, J.S., Pfrimer, K., Ferrioli, E., Kemp, R., Marchini, J.S., et al. Nutritional status, fecal elastase-1, and 13C-labeled mixed triglyceride breath test in the long-term after pancreaticoduodenectomy. Pancreas. 43 (2014), 445–450.
49. Conwell, D.L., Zuccaro, G., Morrow, J.B., van Lente, F., Obuchowski, N., Vargo, J.J., et al. Cholecystokinin-stimulated peak lipase concentration in duodenal drainage fluid: A new pancreatic function test. Am J Gastroenterol. 97 (2002), 1392–1397.
50. Erchinger, F., Engjom, T., Tjora, E., Hoem, D., Hausken, T., Gilja, O.H., et al. Quantification of pancreatic function using a clinically feasible short endoscopic secretin test. Pancreas. 42 (2013), 1101–1106.
51. Sanyal, R., Stevens, T., Novak, E., Veniero, J.C., Secretin-enhanced MRCP:, review of technique and application with proposal for quantification of exocrine function. AJR Am J Roentgenol. 198 (2012), 124–132.
52. Manfredi, R., Perandini, S., Mantovani, W., Frulloni, L., Faccioli, N., Pozzi Mucelli, R., Quantitative MRCP assessment of pancreatic exocrine reserve and its correlation with faecal elastase-1 in patients with chronic pancreatitis. Radiol Med. 117 (2012), 282–292.
53. Stevens, T., Dumot, J.A., Parsi, M.A., Zuccaro, G., Vargo, J.J., Combined endoscopic ultrasound and secretin endoscopic pancreatic function test in patients evaluated for chronic pancreatitis. Dig Dis Sci. 55 (2010), 2681–2687.
54. Albashir, S., Bronner, M.P., Parsi, M.A., Walsh, R.M., Stevens, T., Endoscopic ultrasound, secretin endoscopic pancreatic function test, and histology: Correlation in chronic pancreatitis. Am J Gastroenterol. 105 (2010), 2498–2503.
55. Nakamura, H., Murakami, Y., Uemura, K., Hayashidani, Y., Sudo, T., Ohge, H., et al. Reduced pancreatic parenchymal thickness indicates exocrine pancreatic insufficiency after pancreatoduodenectomy. J Surg Res. 171 (2011), 473–478.
56. Leeds, J.S., Hopper, A.D., Sidhu, R., Simmonette, A., Azadbakht, N., Hoggard, N., et al. Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency. Clin Gastroenterol Hepatol. 8 (2010), 433–438.
57. Fabian, E., Kump, P., Krejs, G.J., Diarrhea caused by circulating agents. Gastroenterol Clin North Am. 41 (2012), 603–610.
58. Jensen, R.T., Overview of chronic diarrhea caused by functional neuroendocrine neoplasms. Semin Gastrointest Dis. 10 (1999), 156–172.
59. Brelian, D., Tenner, S., Diarrhoea due to pancreatic diseases. Best Pract Res Clin Gastroenterol. 26 (2012), 623–631.
60. Roerig, J.L., Steffen, K.J., Mitchell, J.E., Zunker, C., Laxative abuse: epidemiology, diagnosis and management. Drugs. 70 (2010), 1487–1503.
61. Abraham, B.P., Sellin, J.H., Drug-induced, factitious, & idiopathic diarrhoea. Best Pract Res Clin Gastroenterol. 26 (2012), 633–648.
62. Schiller, L.R., Rivera, L.M., Santangelo, W.C., Little, K.H., Fordtran, J.S., Diagnostic value of fasting plasma peptide concentrations in patients with chronic diarrhea. Dig Dis Sci. 39 (1994), 2216–2222.
63. Modlin, I.M., Kidd, M., Bodei, L., Drozdov, I., Aslanian, H., The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract. Am J Gastroenterol. 110 (2015), 1223–1232.
64. Marotta, V., Nuzzo, V., Ferrara, T., Zuccoli, A., Masone, M., Nocerino, L., et al. Limitations of Chromogranin A in clinical practice. Biomarkers. 17 (2012), 186–191.
65. Van Essen, M., Sundin, A., Krenning, E.P., Kwekkeboom, D.J., Neuroendocrine tumours: The role of imaging for diagnosis and therapy. Nat Rev Endocrinol. 10 (2014), 102–114.
66. Byers, R.J., Marsh, P., Parkinson, D., Haboubi, N.Y., Melanosis coli is associated with an increase in colonic epithelial apoptosis and not with laxative use. Histopathology. 30 (1997), 160–164.
67. Eherer, A.J., Fordtran, J.S., Fecal osmotic gap and pH in experimental diarrhea of various causes. Gastroenterology. 103 (1992), 545–551.
68. Longstreth, G.F., Thompson, W.G., Chey, W.D., Houghton, L.A., Mearin, F., Spiller, R.C., Functional bowel disorders. Gastroenterology. 130 (2006), 1480–1491.
69. Money, M.E., Camilleri, M., Review: Management of postprandial diarrhea syndrome. Am J Med. 125 (2012), 538–544.
70. Macaigne, G., Lahmek, P., Locher, C., Lesgourgues, B., Costes, L., Nicolas, M.P., et al. Microscopic colitis or functional bowel disease with diarrhea: A French prospective multicenter study. Am J Gastroenterol. 109 (2014), 1461–1470.
71. Fan, X., Sellin, J.H., Review article: Small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea. Aliment Pharmacol Ther. 29 (2009), 1069–1077.
72. Wedlake, L., A'Hern, R., Russell, D., Thomas, K., Walters, J.R., Andreyev, H.J., Systematic review: The prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 30 (2009), 707–717.
73. Magro, F., Langner, C., Driessen, A., Ensari, A., Geboes, K., Mantzaris, G.J., et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis. 7 (2013), 827–851.
74. Fernandez-Banares, F., Salas, A., Esteve, M., Pardo, L., Casalots, J., Forne, M., et al. Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: A population-based study. Inflamm Bowel Dis. 17 (2011), 1015–1020.
75. Fernandez-Banares, F., Salas, A., Forne, M., Esteve, M., Espinos, J., Viver, J.M., Incidence of collagenous and lymphocytic colitis: A 5-year population-based study. Am J Gastroenterol. 94 (1999), 418–423.
76. Guagnozzi, D., Lucendo, A.J., Angueira-Lapena, T., Gonzalez-Castillo, S., Tenias Burillo, J.M., Prevalence and incidence of microscopic colitis in patients with diarrhoea of unknown aetiology in a region in central Spain. Dig Liver Dis. 44 (2012), 384–388.
77. Pardi, D.S., Loftus, E.V. Jr., Smyrk, T.C., Kammer, P.P., Tremaine, W.J., Schleck, C.D., et al. The epidemiology of microscopic colitis: A population based study in Olmsted County, Minnesota. Gut. 56 (2007), 504–508.
78. Olesen, M., Eriksson, S., Bohr, J., Jarnerot, G., Tysk, C., Microscopic colitis: A common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut. 53 (2004), 346–350.
79. Limsui, D., Pardi, D.S., Smyrk, T.C., Abraham, S.C., Lewis, J.T., Sanderson, S.O., et al. Observer variability in the histologic diagnosis of microscopic colitis. Inflamm Bowel Dis. 15 (2009), 35–38.
80. Fiehn, A.M., Bjornbak, C., Warnecke, M., Engel, P.J., Munck, L.K., Observer variability in the histopathologic diagnosis of microscopic colitis and subgroups. Hum Pathol. 44 (2013), 2461–2466.
81. Aust, D.E., Münch, A., Olesen, M., Vieth, M., Bonderup, O.K., Bohr, J., et al. Su1183 topographical distribution of collagenous colitis — a pooled histological analysis of 2 European prospective multicenter trials. Gastroenterology., 144, 2013 S- S421.
82. Wilcox, C., Turner, J., Green, J., Systematic review: The management of chronic diarrhoea due to bile acid malabsorption. Aliment Pharmacol Ther. 39 (2014), 923–939.
83. Khalid, U., Lalji, A., Stafferton, R., Andreyev, J., Bile acid malabsoption: A forgotten diagnosis?. Clin Med. 10 (2010), 124–126.
84. Nyhlin, H., Merrick, M.V., Eastwood, M.A., Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT. Gut. 35 (1994), 90–93.
85. Lenicek, M., Duricova, D., Komarek, V., Gabrysova, B., Lukas, M., Smerhovsky, Z., et al. Bile acid malabsorption in inflammatory bowel disease: Assessment by serum markers. Inflamm Bowel Dis. 17 (2011), 1322–1327.
86. Ung, K.A., Gillberg, R., Kilander, A., Abrahamsson, H., Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut. 46 (2000), 170–175.
87. Phillips, F., Muls, A.C., Lalji, A., Andreyev, H.J., Are bile acid malabsorption and bile acid diarrhoea an important cause of diarrhoea complicating cancer therapy?. Colorectal Dis. 17 (2015), 730–734.
88. Vijayvargiya, P., Camilleri, M., Shin, A., Saenger, A., Methods for diagnosis of bile acid malabsorption in clinical practice. Clin Gastroenterol Hepatol. 11 (2013), 1232–1239.
89. Barkun, A.N., Love, J., Gould, M., Pluta, H., Steinhart, H., Bile acid malabsorption in chronic diarrhea: Pathophysiology and treatment. Can J Gastroenterol. 27 (2013), 653–659.
90. Suchy, F.J., Brannon, P.M., Carpenter, T.O., Fernandez, J.R., Gilsanz, V., Gould, J.B., et al. NIH consensus development conference statement: Lactose intolerance and health. NIH Consens State Sci Statements. 27 (2010), 1–27.
91. Enattah, N.S., Kuokkanen, M., Forsblom, C., Natah, S., Oksanen, A., Jarvela, I., et al. Correlation of intestinal disaccharidase activities with the C/T-13910 variant and age. World J Gastroenterol. 13 (2007), 3508–3512.
92. Casellas, F., Aparici, A., Casaus, M., Rodríguez, P., Malagelada, J.R., Subjective perception of lactose intolerance does not always indicate lactose malabsorption. Clin Gastroenterol Hepatol. 8 (2010), 581–586.
93. Jellema, P., Schellevis, F.G., van der Windt, D.A., Kneepkens, C.M., Lactose malabsorption and intolerance: a systematic review on the diagnostic value of gastrointestinal symptoms and self-reported milk intolerance. QJM 103 (2010), 555–572.
94. Fernández-Bañares, F., Reliability of symptom analysis during carbohydrate hydrogen-breath tests. Curr Opin Clin Nutr Metab Care. 15 (2012), 494–498.
95. Newcomer, A.D., McGill, D.B., Thomas, P.J., Hofmann, A.F., Prospective comparison of indirect methods for detecting lactase deficiency. N Engl J Med. 293 (1975), 1232–1236.
96. Maiuri, L., Rossi, M., Raia, V., Garipoli, V., Hughes, L.A., Swallow, D., et al. Mosaic regulation of lactase in human adult-type hypolactasia. Gastroenterology. 107 (1994), 54–60.
97. Aragón, J.J., Hermida, C., Martínez-Costa, O.H., Sánchez, V., Martín, I., Sánchez, J.J., et al. Noninvasive diagnosis of hypolactasia with 4-Galactosylxylose (Gaxilose): A multicentre, open-label, phase IIB-III nonrandomized trial. J Clin Gastroenterol. 48 (2014), 29–36.
98. Hermida, C., Martínez-Costa, O.H., Corrales, G., Teruel, C., Sánchez, V., Sánchez, J.J., et al. Improvement and validation of d-xylose determination in urine and serum as a new tool for the noninvasive evaluation of lactase activity in humans. J Clin Lab Anal. 28 (2014), 478–486.
99. Vernia, P., di Camillo, M., Foglietta, T., Avallone, V.E., De Carolis, A., Diagnosis of lactose intolerance and the ‘nocebo’ effect: The role of negative expectations. Dig Liver Dis. 42 (2010), 616–619.
100. Swallow, D.M., Genetics of lactase persistence and lactose intolerance. Annu Rev Genet. 37 (2003), 197–219.
101. Pohl, D., Savarino, E., Hersberger, M., Behlis, Z., Stutz, B., Goetze, O., et al. Excellent agreement between genetic and hydrogen breath tests for lactase deficiency and the role of extended symptom assessment. Br J Nutr. 104 (2010), 900–907.
102. Krawczyk, M., Wolska, M., Schwartz, S., Gruenhage, F., Terjung, B., Portincasa, P., et al. Concordance of genetic and breath tests for lactose intolerance in a tertiary referral centre. J Gastrointestin Liver Dis. 17 (2008), 135–139.
103. Mattar, R., Monteiro, M.S., Villares, C.A., dos Santos, A.F., Carrilho, F.J., Single nucleotide polymorphism C/T(-13910), located upstream of the lactase gene, associated with adult-type hypolactasia: Validation for clinical practice. Clin Biochem 41 (2008), 628–630.
104. Fernández-Bañares, F., Esteve, M., Viver, J.M., Fructose-sorbitol malabsorption. Curr Gastroenterol Rep. 11 (2009), 368–374.
105. Frieling, T., Kuhlbusch-Zicklam, R., Kalde, S., Heise, J., Hülsdonk, A., Kreysel, C., Fructose malabsorption: How much fructose can a healthy subject tolerate?. Digestion. 84 (2011), 269–272.
106. Kyaw, M.H., Mayberry, J.F., Fructose malabsorption: True condition or a variance from normality. J Clin Gastroenterol. 45 (2011), 16–21.
107. Gibson, P.R., Varney, J., Malakar, S., Muir, J.G., Food components and irritable bowel syndrome. Gastroenterology., 148, 2015 1158.e4- 1174.e4.
108. Stanghellini, V., Cogliandro, R.F., de Giorgio, R., Barbara, G., Morselli-Labate, A.M., Cogliandro, L., et al. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: A single center study. Clin Gastroenterol Hepatol. 3 (2005), 449–458.
109. Knowles, C.H., Lindberg, G., Panza, E., de Giorgio, R., New perspectives in the diagnosis and management of enteric neuropathies. Nat Rev Gastroenterol Hepatol. 10 (2013), 206–218.
110. Camilleri, M., Bharucha, A.E., di Lorenzo, C., Hasler, W.L., Prather, C.M., Rao, S.S., et al. American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil. 20 (2008), 1269–1282.
111. Camilleri, M., Hasler, W.L., Parkman, H.P., Quigley, E.M., Soffer, E., Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology. 115 (1998), 747–762.
112. Parkman, H.P., Jones, M.P., Tests of gastric neuromuscular function. Gastroenterology. 136 (2009), 1526–1543.
113. Johansson, S.G., Hourihane, J.O., Bousquet, J., Bruijnzeel-Koomen, C., Dreborg, S., Haahtela, T., et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 56 (2001), 813–824.
114. Chafen, J.J., Newberry, S.J., Riedl, M.A., Bravata, D.M., Maglione, M., Suttorp, M.J., et al. Diagnosing and managing common food allergies: A systematic review. JAMA. 303 (2010), 1848–1856.
115. Turnbull, J.L., Adams, H.N., Gorard, D.A., Review article: The diagnosis and management of food allergy and food intolerances. Aliment Pharmacol Ther. 41 (2015), 3–25.
116. Lomer, M.C., Review article: The aetiology, diagnosis, mechanisms and clinical evidence for food intolerance. Aliment Pharmacol Ther. 41 (2015), 262–275.
117. Nwaru, B.I., Hickstein, L., Panesar, S.S., Roberts, G., Muraro, A., Sheikh, A., et al. Prevalence of common food allergies in Europe: A systematic review and meta-analysis. Allergy. 69 (2014), 992–1007.
118. Böhn, L., Störsrud, S., Törnblom, H., Bengtsson, U., Simrén, M., Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol. 108 (2013), 634–641.
119. Aydinlar, E.I., Dikmen, P.Y., Tiftikci, A., Saruc, M., Aksu, M., Gunsoy, H.G., et al. IgG-based elimination diet in migraine plus irritable bowel syndrome. Headache. 53 (2013), 514–525.
120. Atkinson, W., Sheldon, T.A., Shaath, N., Whorwell, P.J., Food elimination based on IgG antibodies in irritable bowel syndrome: A randomised controlled trial. Gut. 53 (2004), 1459–1464.
121. Ligaarden, S.C., Lydersen, S., Farup, P.G., IgG and IgG4 antibodies in subjects with irritable bowel syndrome: A case control study in the general population. BMC Gastroenterol., 12, 2012, 166.
122. Hamilton, R.G., Clinical laboratory assessment of immediate-type hypersensitivity. J Allergy Clin Immunol. 125:2 Suppl 2 (2010), S284–S296.
123. Soares-Weiser, K., Takwoingi, Y., Panesar, S.S., Muraro, A., Werfel, T., Hoffmann-Sommergruber, K., et al. The diagnosis of food allergy: A systematic review and meta-analysis. Allergy. 69 (2014), 76–86.
124. Ortolani, C., Bruijnzeel-Koomen, C., Bengtsson, U., Bindslev-Jensen, C., Björkstén, B., Høst, A., et al. Controversial aspects of adverse reactions to food. European Academy of Allergology and Clinical Immunology (EAACI) reactions to Food Subcommittee. Allergy. 54 (1999), 27–45.
125. Fasano, A., Sapone, A., Zevallos, V., Schuppan, D., Nonceliac gluten sensitivity. Gastroenterology. 148 (2015), 1195–1204.